Pila Pharma AB (publ) (PILA.ST)
SEK 3.87
(5.16%)
SEK 3.87
(5.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.46 Million | 1.88 Million | 719.23 Thousand | - | 346.43 Thousand | - |
| Cost of Revenue | - | 10.76 Million | 38.29 Thousand | 492.39 Thousand | 2.42 Million | 2.93 Million |
| Gross Profit | 1.46 Million | -8.88 Million | 680.93 Thousand | -492.39 Thousand | -2.08 Million | -2.93 Million |
| Operating Expenses | 7.85 Million | 10.77 Million | 9.94 Million | 2.88 Million | 2.63 Million | 2.01 Million |
| Selling, General and Administrative Expenses | - | 958.00 | 5.07 Million | 1.5 Million | 1.48 Million | 785.42 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 7.85 Million | 10.77 Million | 4.87 Million | 1.38 Million | 1.15 Million | 1.23 Million |
| Cost and Expenses | 7.85 Million | 10.77 Million | 9.97 Million | 3.37 Million | 5.06 Million | 4.95 Million |
| Operating Income | -6.39 Million | -8.89 Million | -9.26 Million | -3.37 Million | -4.71 Million | -4.95 Million |
| Interest Expense | 40.08 Thousand | 658.00 | 30.54 Thousand | 202.00 | 882.00 | 944.00 |
| Income Tax Expense | - | 17.88 Million | 7.94 Million | 3.6 Million | 3.95 Million | -650 Thousand |
| Earnings before Tax | -9.93 Million | -26.77 Million | -17.2 Million | -6.98 Million | -8.66 Million | -5.6 Million |
| Net Income | -9.93 Million | -44.66 Million | -25.15 Million | -10.58 Million | -12.61 Million | -5.6 Million |
| Earnings Per Share Basic | -0.47 | -2.59 | -1.88 | -0.67 | -0.80 | -0.36 |
| Earnings Per Share Diluted | -0.47 | -2.59 | -1.88 | -0.67 | -0.80 | -0.36 |
| Weighted Average Shares Outstanding | 21.1 Million | 17.25 Million | 13.39 Million | 15.7 Million | 15.7 Million | 15.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.1 Million | 17.25 Million | 13.39 Million | 15.7 Million | 15.7 Million | 15.7 Million |
| Gross Margin | 1.00 | -4.73 | 0.95 | - | -6.01 | - |
| EBIT Margin | -6.02 | -4.72 | -12.85 | - | -13.56 | - |
| Profit Margin | -6.79 | -23.75 | -34.97 | - | -36.43 | - |
| EBITDA | -8.81 Million | -26.76 Million | -17.15 Million | -3.35 Million | -8.64 Million | -4.93 Million |
| Earnings Before Tax Margin | -4.37 | -4.73 | -12.88 | - | -13.62 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 341.5 Thousand | 341.5 Thousand | 1.46 Million | 366 Thousand | - | 301 Thousand |
| Cost of Revenue | 1.8 Million | 1.8 Million | 6.77 Million | 1.37 Million | 269 Thousand | 2.05 Million |
| Gross Profit | -1.46 Million | -1.46 Million | -5.31 Million | -1 Million | -269 Thousand | -1.75 Million |
| Operating Expenses | 579 Thousand | 579 Thousand | 1.07 Million | 270 Thousand | 1.51 Million | 2.05 Million |
| Selling, General and Administrative Expenses | 309.5 Thousand | 309.5 Thousand | - | 3.66 Million | 1.24 Million | 916 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 269.5 Thousand | 269.5 Thousand | -1.07 Million | -270 Thousand | - | - |
| Cost and Expenses | 2.38 Million | 2.38 Million | 7.85 Million | 1.64 Million | 1.51 Million | 2.05 Million |
| Operating Income | -2.04 Million | -2.04 Million | -6.39 Million | -1.27 Million | -1.51 Million | -1.75 Million |
| Interest Expense | - | - | 40 Thousand | 27 Thousand | 12 Thousand | 1000.00 |
| Income Tax Expense | - | - | -249.00 | -249.00 | 308.58 Thousand | 146.91 Thousand |
| Earnings before Tax | -2.04 Million | -2.04 Million | -9.93 Million | -1.3 Million | -1.53 Million | -3.05 Million |
| Net Income | -2.04 Million | -2.04 Million | -9.93 Million | -1.3 Million | -1.53 Million | -3.05 Million |
| Earnings Per Share Basic | -0.09 | -0.09 | - | -0.06 | -0.08 | -0.17 |
| Earnings Per Share Diluted | -0.09 | -0.09 | - | -0.06 | -0.08 | -0.17 |
| Weighted Average Shares Outstanding | 23.79 Million | 23.79 Million | 21.1 Million | 21.1 Million | 18.4 Million | 18.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 23.79 Million | 23.79 Million | 21.1 Million | 21.1 Million | 18.4 Million | 18.4 Million |
| Gross Margin | -4.28 | -4.28 | -3.63 | -2.74 | - | -5.84 |
| EBIT Margin | -5.19 | -5.19 | - | -2.75 | - | -4.94 |
| Profit Margin | -5.98 | -5.98 | -6.79 | -3.55 | - | -10.16 |
| EBITDA | -1.77 Million | -1.77 Million | - | -1 Million | -1.24 Million | -1.48 Million |
| Earnings Before Tax Margin | -5.98 | -5.98 | -4.37 | -3.48 | - | -5.84 |
SHUBHAM
MPL
TTFL
THCH
2034
EVSV